Schedule 13G ownership disclosure
REATA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 75615P103
Event date: 2016-05-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,640,473
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-16-125678
- Form type
- SC 13G
- Filer
- AbbVie Inc.
- CIK
- CIK 1551152
- Filed
- Jun 06, 2016
- Reporting period
- May 25, 2016
- Description
- Schedule 13G beneficial ownership